openPR Logo
Press release

Digital Pathology Market Current Scenario with Forecast to 2031

04-02-2024 05:30 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: InsightAce Analytic Pvt.Ltd

/ PR Agency: InsightAce Analytic Pvt.Ltd
Digital Pathology Market Current Scenario with Forecast to 2031

Digital Pathology Market

Digital Pathology Market to reach over USD 2731.95 million by the year 2031 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2024-2031"

The global digital pathology market is estimated to reach over USD 2731.95 million by 2024-2031, exhibiting a CAGR of 12.91% during the forecast period.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1629

The main factors driving the market's expansion include:
• The rising incidence of cancer.
• The growing usage of digital pathology in internet and pharmaceutical research.
• The growing adoption of digital pathology as a means of enhancing lab productivity.

The increasing occurrence of cardiovascular illnesses is a crucial source for creating cutting-edge diagnostic methodologies. As a result, during the forecast period, the demand for digital pathology systems will develop and propel the market's expansion. Furthermore, it is anticipated that technological advances like computerization, robotic light microscopy, and various fibre optic links will contribute to the growing use of digital pathology. The advent of cost-effective scanners and small players' inclination to digitize the pathology process has driven the market's rise in recent years.

Furthermore, the introduction of cloud-based technology makes it possible to save digital slides linked to pathologists' secured access, which is anticipated to support the market's prospective expansion for digital pathology. Nevertheless, the use of these systems is expected to be constrained by their high cost and the difficulty of finding qualified workers to operate digital pathology equipment.

List of Prominent Players in the Digital Pathology Market:

• Biosystems (US)
• Koninklijke Philips N.V. (Netherlands)
• Hamamatsu Photonics (Japan)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• 3DHISTECH (Hungary)
• Apollo Enterprise Imaging (US)
• XIFIN, Inc. (US)
• Huron Digital Pathology (Canada)
• Visiopharm A/S (Denmark)
• Aiforia Technologies Oy (Finland)
• Akoya Biosciences (US)
• Corista (US)
• Indica Labs (US)
• Objective Pathology Services (Canada)
• Sectra AB (Sweden)
• OptraSCAN (US)
• Glencoe Software (US)
• KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)
• Inspirata, Inc. (US)
• PathAI (US)
• Proscia Inc. (US)
• Kanteron Systems (Spain)
• Mikroscan Technologies (US)
• Motic (US)
• Paige (US)

Market Dynamics:
Drivers-
The success of digital pathology in research is driving the demand for these systems from the cancer research sector. This also attracts government investors to invest in digital pathology systems for clinical diagnostics applications. Technological advancements such as computerization, robotic light microscopy, and multiple fiber optic communications are important key factors projected to increase the adoption of {{keyword}} in the future.

Great-throughput technologies for drug discovery are also in high demand, which could help the device catch on. The adoption of pathological digitization may also increase demand for the services. These elements could fuel market expansion for digital pathology.

Challenges:

Inhibitors to market expansion over the forecast period include strict regulatory concerns for primary diagnosis and a lack of uniform norms for digital pathology. Inhibitors to market expansion over the forecast period include strict regulatory concerns for primary diagnosis and a lack of uniform norms for digital pathology. The deployment of these devices is anticipated to be constrained by their high cost and the difficulty of finding qualified individuals to operate digital pathology devices.

Regional Trends:
North America has a mature market for digital pathology products in the field of marketing during the forecast period. The growing prevalence of cancer, the expanding use of digital pathology in pharmaceutical research and online as part, and the ever-increasing acceptance of digital pathology to improve lab efficiency are the primary drivers of the market's growth. Besides, Europe had a substantial share of the digital pathology market. The need for digital pathology increased as customers' preferences for digital tools increased. Additionally, expanding the use of products with advanced technology is likely to support market expansion.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1629

Recent Developments:

• In March 2022-Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform for use in clinical laboratories and to conduct diagnostic and clinical research, was introduced by Thermo Fisher Scientific, Inc. with the CE-IVD marking.

• In April 2022-A contract between the Catalan Health Institute and 3DHISTECH Ltd. was signed. This plan was implemented to introduce digital pathology tools across an eight-hospital network.

Segmentation of Digital Pathology Market-

By Product

• Scanners
o Brightfield
o Other Scanners
• Software
o Integrated Software
o Standalone Software
 Information Management Software
 Image Analysis Software
• Storage Systems

By Type

• Human Pathology
• Veterinary Pathology

By Application

• Drug Discovery
• Disease Diagnosis
• Training & Education

By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes

By Region-
North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/digital-pathology-market/1629

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Pathology Market Current Scenario with Forecast to 2031 here

News-ID: 3449638 • Views:

More Releases from InsightAce Analytic Pvt.Ltd

Biosimilar Monoclonal Antibodies Market Latest Report with Forecast to 2031
Biosimilar Monoclonal Antibodies Market Latest Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biosimilar Monoclonal Antibodies Market- by Product (Infliximab, Trastuzumab, Rituximab, Adalimumab, Bevacizumab, Cetuximab, Ranibizumab, Denosumab, Eculizumab and Other Pipeline Products), Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders and Other Indication), Trends, Industry Competition Analysis, Revenue and Forecast To 2024- 2030." Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1218 InsightAce Analytic's most recent study
Cell and Gene Therapy Supply Chain/Logistics Market Reviews Analysis Report 2024
Cell and Gene Therapy Supply Chain/Logistics Market Reviews Analysis Report 2024
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell and Gene Therapy Supply Chain/Logistics Market (By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), By Mode of Deployment
Preclinical Oncology Models Market - Recent Innovations and Upcoming Trends Analysis
Preclinical Oncology Models Market - Recent Innovations and Upcoming Trends Anal …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Preclinical Oncology Models Market- by Product (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model and Others), Application (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Fibrosarcoma, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer and Others),
2D Materials Market 2024-2031 | Exclusive Study Report
2D Materials Market 2024-2031 | Exclusive Study Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 2D Materials Market Size, Share & Trends Analysis Report By Material (Graphene, Black Phosphorous, Transition Metal Dichalcogenides, Mxenes, Hexagonal Boron Nitride), And End Users (Composite And Coating, Energy Storage Devices, Electronics, Semiconductors, Pharmaceuticals, Automobiles )- Market Outlook And Industry Analysis 2031" The 2D Materials market will reach over USD 36.27 billion by 2024-2031, exhibiting

All 5 Releases


More Releases for Pathology

Pathological Examination Market by Type (Traditional Pathology and Digital Patho …
According to a new report published by Allied Market Research, titled, "Pathological Examination Market: Global Opportunity Analysis and Industry Forecast, 2017-2025" The global pathological examination market share was valued to be at $171 billion in 2017 and is expected to reach $438 billion by 2025, registering a CAGR of 12.3% from 2019 to 2025. Pathology is a study that involves diagnosis of diseases through examination of bodily fluids such as
Digital Pathology Market 2023 by Key Players Analysis - Danaher Corporation, Ham …
The global digital pathology market is projected to showcase extensive growth during the forecast period, mainly due to increasing adoption of digital pathology products to improve the efficiency of laboratories across the globe, and rising government initiatives in collaboration with market players to raise awareness about the advanced digital pathology products and technologies. Browse report sample at: https://www.psmarketresearch.com/market-analysis/digital-pathology-market/report-sample Based on product, the digital pathology market is bifurcated into software, scanner, communication systems,
Digital Pathology Market: Rise in Installation of Digital Pathology Systems to B …
Transparency Market Research (TMR) has published a new report titled, “Digital Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global digital pathology market was valued at US$ 340 Mn in 2017, and it is projected to expand at a CAGR of more than 12% from 2018 to 2026. Increase in installation of digital systems and workload of pathologists is projected
Digital Pathology Market: Rise in Installation of Digital Pathology Systems to B …
The global digital pathology market is expanding at a rapid pace, driven by increase in installation of digital pathology systems. The global market was valued at US$ 340 Mn in 2017 and is projected to reach more than US$ 900 Mn by 2026, expanding at a CAGR of more than 12% from 2018 to 2026. The global digital pathology market is witnessing expansion at a relatively higher growth rate owing
2nd International Conference on Pathology and Surgical Pathology
2nd International conference on Pathology and Surgical Pathology which is structured on March 27-28, 2019 in Melbourne, Australia with the Theme ‘Revamping Innovations in Pathology and Surgical Pathology’. Surgical pathology 2019 mission is to provide premier research topics to all the participants to expand the knowledge and increase expertise. The ultimate vision Surgical Pathology 2019 is to be exclusive conference about surgical pathology in health care which assure different technical and innovative ideas. -- 47 church field road
Euro Surgical Pathology 2018
Rome, Italy welcomes you all to share Medical Knowledge and Experience at our upcoming "14th International Conference on Surgical Pathology and Cancer Diagnosis, May 17-18, 2018. Some of the main sessions "to-be-covered" are • Surgical Pathology and Diagnosis • Cancer Pathology • Breast Pathology • Gynecologic Pathology • Gastrointestinal and Liver Pathology • Neuro Surgery and Pathology • Oral and Maxillofacial Pathology • Dermatopathology • Genitourinary Pathology • Cytopathology & many more! Holiday Inn Rome - Aurelia Via Aurelia Km 8,400 00163 Roma Italy